现代免疫学的发展为肿瘤研究开拓了新的途径。免疫疗法在某些恶性肿瘤的防治中受到广泛的重视。厌氧棒状杆菌是一种强的非特异性免疫激活剂,能增强机体抗肿瘤的能力(1)。经动物实验和临床试用,对某些肿瘤有一定抗癌效果。厌氧棒状杆菌(Anaerobic Corynebacterum)是革兰氏阳性菌,现属丙酸杆菌(Propion-ibacteria)(2、3),1897年Roux初次分离成功,1964年法国Halpern发现此菌具有刺激网状内 The development of modern immunology has opened up new avenues for cancer research. Immunotherapy has received extensive attention in the prevention and treatment of certain malignant tumors. Anaerobic coryneform bacteria is a strong non-specific immune activator that enhances the body’s ability to fight cancer (1). Animal experiments and clinical trials have certain anti-cancer effects on certain tumors. Anaerobic Corynebacterum is a gram-positive bacterium, which is now Propion-ibacteria (2, 3). In 1897, Roux was successfully isolated for the first time. In 1964, Halpern in France discovered that this bacterium had a reticular reticular formation.